No Role of Osteocytic Osteolysis in the Development and Recovery of the Bone Phenotype Induced by Severe Secondary Hyperparathyroidism in Vitamin D Receptor Deficient Mice

Int J Mol Sci. 2020 Oct 27;21(21):7989. doi: 10.3390/ijms21217989.

Abstract

Osteocytic osteolysis/perilacunar remodeling is thought to contribute to the maintenance of mineral homeostasis. Here, we utilized a reversible, adult-onset model of secondary hyperparathyroidism to study femoral bone mineralization density distribution (BMDD) and osteocyte lacunae sections (OLS) based on quantitative backscattered electron imaging. Male mice with a non-functioning vitamin D receptor (VDRΔ/Δ) or wild-type mice were exposed to a rescue diet (RD) (baseline) and subsequently to a low calcium challenge diet (CD). Thereafter, VDRΔ/Δ mice received either the CD, a normal diet (ND), or the RD. At baseline, BMDD and OLS characteristics were similar in VDRΔ/Δ and wild-type mice. The CD induced large cortical pores, osteomalacia, and a reduced epiphyseal average degree of mineralization in the VDRΔ/Δ mice relative to the baseline (-9.5%, p < 0.05 after two months and -10.3%, p < 0.01 after five months of the CD). Switching VDRΔ/Δ mice on the CD back to the RD fully restored BMDD to baseline values. However, OLS remained unchanged in all groups of mice, independent of diet. We conclude that adult VDRΔ/Δ animals on an RD lack any skeletal abnormalities, suggesting that VDR signaling is dispensable for normal bone mineralization as long as mineral homeostasis is normal. Our findings also indicate that VDRΔ/Δ mice attempt to correct a calcium challenge by enhanced osteoclastic resorption rather than by osteocytic osteolysis.

Keywords: bone mineralization density distribution; mice with a non-functioning vitamin D receptor; osteocyte lacunae sections; osteocytic osteolysis; quantitative backscattered electron imaging; vitamin D receptor.

MeSH terms

  • Animals
  • Bone Density / drug effects
  • Calcium, Dietary / administration & dosage*
  • Calcium, Dietary / pharmacology
  • Disease Models, Animal
  • Homeostasis
  • Hyperparathyroidism, Secondary / diagnostic imaging
  • Hyperparathyroidism, Secondary / drug therapy*
  • Hyperparathyroidism, Secondary / genetics
  • Male
  • Mice
  • Osteocytes / drug effects*
  • Osteolysis / diagnostic imaging
  • Osteolysis / drug therapy*
  • Phenotype
  • Receptors, Calcitriol / deficiency*
  • Signal Transduction

Substances

  • Calcium, Dietary
  • Receptors, Calcitriol
  • Vdr protein, mouse